MP Swati Maliwal Exposes Pharma Profiteering: 600-1100% Markups on Medicines

• Rajya Sabha MP Swati Maliwal highlighted pharmaceutical companies making 600-1100% profit on medicines in Parliament.
• She cited examples like Cetirizine, sold for ₹21.06 with a stockist price of ₹1.52, and Ibuprofen with a 109% price variation among insulin brands.
• Maliwal questioned Union Health Minister Jagat Prakash Nadda on regulating profiteering and making medicines affordable.
• Minister Nadda stated that drug pricing policy is a continuous, transparent process, reviewed periodically with stakeholder input.
• Maliwal also revealed a 2024 audit showing a pharma company spent ₹2 crore to take 30 doctors to Paris, questioning action taken and new laws.

Why It Matters: MP Swati Maliwal exposed massive pharmaceutical profiteering and doctor incentives, urging government regulation for affordable medicines.